From Raynaud Phenomenon to Systemic Sclerosis in COVID-19: A Case Report.
Journal
Advances in skin & wound care
ISSN: 1538-8654
Titre abrégé: Adv Skin Wound Care
Pays: United States
ID NLM: 100911021
Informations de publication
Date de publication:
01 Feb 2022
01 Feb 2022
Historique:
pubmed:
12
10
2021
medline:
27
1
2022
entrez:
11
10
2021
Statut:
ppublish
Résumé
In 2019, the novel SARS-CoV-2 infection emerged, causing the disease called COVID-19, which primarily affects the respiratory tract and lung at alveolar and interstitial levels. Systemic sclerosis (SSc) is an autoimmune connective disease characterized by vascular abnormalities and diffuse and progressive fibrosis of the skin and internal organs. Raynaud phenomenon (RP) occurs in virtually all patients affected by SSc and, in most cases, is an onset symptom of the disease; that is, RP may appear several years before overt illness. Although the exact pathophysiologic pathways leading to RP and SSc are still unknown, several infectious agents, especially viruses, have been suggested as possible triggering factors. Here, the authors describe the first case of RP secondary to SSc following SARS-CoV-2 infection.
Identifiants
pubmed: 34629385
doi: 10.1097/01.ASW.0000795240.63966.53
pii: 00129334-202202000-00012
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
123-124Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis: demographic, clinical, and serological features and survival in 1012 patients. Medicine 2002;81:139–53.
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395(10234):1417–8.
Minier T, Guiducci S, Bellando-Randone S, et al. Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fngers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis 2014;73:2093–7.
Giuggioli D, Manfredi A, Lumetti F, Colaci M, Ferri C. Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. Autoimmun Rev 2018;17(2):155–64.
Vacchi C, Meschiari M, Milic J, et al. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford) 2020;59(12):e147–50.
Ehrenfeld M, Tincani A, Andreoli L, et al. COVID-19 and autoimmunity. Autoimmun Rev 2020;19(8):102597.
Ferri C, Giuggioli D, Colaci M. Viral infections and systemic sclerosis. Clin Exp Rheumatol 2014;32(6 Suppl 86):S–229.
Ratchford SM, Stickford JL, Province VM, et al. Vascular alterations among young adults with SARS-CoV-2. Am J Physiol Heart Circ 2021;320:H404–10.